- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02724605
The Effect of Red Blood Cells Storage Duration on Biochemical Changes in Pediatric Patients
January 4, 2018 updated by: Abdelrady S Ibrahim, MD
Is Intraoperative Red Blood Cells Transfusion With Different Storage Duration Has Effect on Some Biochemical Parameters in Pediatric Trauma Patients Need Intraoperative Transfusion?
The aim of the study is to detect if the storage duration of red blood cells has impact on some biochemical parameters after intra operative transfusion in pediatric trauma patient
Study Overview
Status
Completed
Conditions
Detailed Description
A pretransfusion draw of a few drops of patient venous blood, send for analysis by i-STAT Portable Clinical Analyser. Samples are processed immediately and provide laboratory quality results in 2 minutes using the CHEM 8+ i-STAT cartridge for measurement of:
- Potassium (K)
- Ionized Calcium (iCa)
- Glucose (Glu)
- Urea Nitrogen (BUN)/Urea
- Hemoglobin (Hb) and Hematocrit (Hct).
- Concurrently, a few drops of blood will be taken from the unit to be transfused will be analysed by i-STAT Portable Clinical Analyser for measurement of previous biochemical parameters.
- The details of the unit, such as draw date, volume of transfusion, and date of transfusion, will be recorded. The RBC unit will be delivered to the operative room from the blood bank in an insulated box.
- The transfusion is then given as clinically indicated at a rate of 50 to 150 mL/h based on the clinician's orders, the patient's weight, and the patient's clinical situation.
- Volumes will be transfused to children according to the following top-up transfusion equation: desired Hemoglobin (Hb) (g/dl) - actual Hemoglobin (Hb) (g/dl) x weight (kg) x 3. (usually 10-20 ml/kg).
- A second patient blood sample will be drawn one hour after the transfusion and will be analyzed by i-STAT Portable Clinical Analyser.
- Patient information will be recorded for age, weight, sex, and primary diagnosis.
- Demographic and clinical variables will be collected, to include type and quantity of all blood products and fluids received and medications administered. All surgical procedures will be documented.
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Assiut, Egypt
- Assiut University Faculty of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 years to 10 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
.ASA I-II physical status patients.
- Genders Eligible for Study : both .
- Age: 2_10 years
- All non-crush trauma pediatric patients need intraoperative RBC transfusion.
- RBCs transfusion Volume within 10-20ml/kg.
Exclusion Criteria:
- Patients with renal failure (serum creatinine 1.5 mg/dL)
- Hepatic insufficiency.
- Furosemide diuresis.
- Succinylcholine for rapid sequence induction.
- Electrolytes disorders.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Group A
Red blood cells unit age 14 days or less
|
30 Patients who will receive units of packed red blood cells stored stored for 14 days or less
|
|
Other: Group B
Red blood cells unit age more than 14 days
|
30 patients who will receive units of packed red blood cells stored for more than 14 days
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Serum potassium level
Time Frame: One hour after red blood cells transfusion
|
Mmol/l
|
One hour after red blood cells transfusion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Serum ionised calcium
Time Frame: One hour after red blood cells transfusion
|
mg/dl
|
One hour after red blood cells transfusion
|
|
Serum glucose level
Time Frame: One hour after red blood cells transfusion
|
Mmol/l
|
One hour after red blood cells transfusion
|
|
Blood Urea Nitrogen
Time Frame: One hour after red blood cells transfusion
|
mg/dL
|
One hour after red blood cells transfusion
|
|
Hemoglobin level
Time Frame: One hour after red blood cells transfusion
|
g/dl
|
One hour after red blood cells transfusion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Abdelrady S Ibrahim, Assistant professor of anesthesia and Intensive Care
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2016
Primary Completion (Actual)
June 1, 2017
Study Completion (Actual)
August 1, 2017
Study Registration Dates
First Submitted
March 20, 2016
First Submitted That Met QC Criteria
March 30, 2016
First Posted (Estimate)
March 31, 2016
Study Record Updates
Last Update Posted (Actual)
January 8, 2018
Last Update Submitted That Met QC Criteria
January 4, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRB0000871236
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Red Blood Cells Transfusion
-
Tel-Aviv Sourasky Medical CenterUnknownRed Blood Cells Transfusion.Israel
-
University of Sao PauloCompletedRed Blood Cells Transfusion | Oncologic SurgeryBrazil
-
Heinrich-Heine University, DuesseldorfCompletedEndothelial Function | Red Blood Cells | Nitric Oxide Pool in Red Blood Cells and Blood PlasmaGermany
-
Population Health Research InstituteRecruitingRed Blood Cell TransfusionCanada
-
Assiut UniversityNot yet recruitingPacked Red Blood Cells
-
Izmir Katip Celebi UniversityCompletedOxygen Consumption | Red Blood Cell TransfusionTurkey
-
Vitalant Research InstituteUniversity of Colorado, DenverCompletedMeasuring Red Blood Cell Survival After TransfusionUnited States
-
Universitair Ziekenhuis BrusselCompletedWhite Blood Cells Engulfing Red Blood CellsBelgium
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR); Canadian Blood ServicesActive, not recruitingRed Blood Cell TransfusionCanada
-
Emory UniversityTerminated
Clinical Trials on Red blood cells unit age 14 days or less
-
Mayo ClinicCompletedBlood Protein Disorders | Pulmonary EdemasUnited States
-
Unity Health TorontoCanadian Blood ServicesCompleted
-
NYU Langone HealthSuspended
-
Università degli Studi di FerraraCompleted
-
Zhejiang Provincial People's HospitalWestlake TherapeuticsNot yet recruitingCancer | Solid Tumor | Hematologic Malignancy
-
San Rocco TherapeuticsActive, not recruitingConfirmed Diagnosis of ß-thalassemia MajorItaly
-
The University of Texas Medical Branch, GalvestonWithdrawn
-
Memorial Sloan Kettering Cancer CenterCompletedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey ClinicCompleted